The shares of world’s seventh largest tyre manufacturer, Apollo Tyres Ltd jumped nearly eight per cent on April 9, after the company announced that it has raised Rs 500 crore through NCDs.

Larsen & Toubro (L&T) has come up with new innovative technologies such as artificial intelligence to help the local authorities in monitoring and implementing measures to combat the spread of COVID-19.

New Fund Offers (NFOs) that are open for subscription.

Zydus Cadila announced that the company has received a final approval from US Food & Drug Administration (USFDA) to market Imatinib Mesylate tablets, 100 mg and 400 mg.

Despite all the fall in the equity market, investors have shown faith in equity as an asset class and poured in Rs 30,109 crore in equity dedicated funds in the month of March 2020.

The key reason for this staggered performance was the lack of any strong trigger that could bring certainty in term of revenue. Further, many regulatory hurdles, such as from USFDA, also made things difficult for these companies.

Granules India informed the bourses on Thursday that its wholly-owned subsidiary, Granules Pharmaceuticals Inc has received approval from the United States Food and Drug Administration (USFDA) for Butalbital, Acetaminophen and Caffeine Capsules USP, 50 mg/300 mg/40 mg.

The shares of Aurobindo Pharma Limited (APL) were trading in green on Thursday after the company announced that it has received final approval from US Food and Drug Administration (USFDA) to manufacture and market Fluoxetine Tablets, 10 mg and 20 mg.

NIIT Limited, a global skills and talent development company, on Thursday, announced that it has specially designed and launched NIIT ‘remote work excellence kit’ course to support India’s fight against COVID-19. The online course has been made available absolutely free on its official portal that is, www.niit.com with an aim to facilitate remote working for adults.

There are various methods used around the globe for goal-based financial planning. Declining glide path is one such method. Read on to find out more.